Cisd2 deficiency drives premature aging and causes mitochondria-mediated defects in mice

  1. Yi-Fan Chen1,
  2. Cheng-Heng Kao2,
  3. Ya-Ting Chen1,3,
  4. Chih-Hao Wang4,
  5. Chia-Yu Wu1,
  6. Ching-Yen Tsai1,
  7. Fu-Chin Liu5,
  8. Chu-Wen Yang6,
  9. Yau-Huei Wei4,
  10. Ming-Ta Hsu4,
  11. Shih-Feng Tsai1,3 and
  12. Ting-Fen Tsai1,3,7
  1. 1Department of Life Sciences and Institute of Genome Sciences, National Yang-Ming University, Taipei 112, Taiwan;
  2. 2Center of General Education, Chang Gung University, Taoyuan 333, Taiwan;
  3. 3Division of Molecular and Genomic Medicine, National Health Research Institutes, Zhunan, Miaoli County 350, Taiwan;
  4. 4Institute of Biochemistry and Molecular Biology, National Yang-Ming University, Taipei 112, Taiwan;
  5. 5Institute of Neuroscience, National Yang-Ming University, Taipei 112, Taiwan;
  6. 6Department of Microbiology, Soochow University, Taipei 111, Taiwan;

    Abstract

    CISD2, the causative gene for Wolfram syndrome 2 (WFS2), is a previously uncharacterized novel gene. Significantly, the CISD2 gene is located on human chromosome 4q, where a genetic component for longevity maps. Here we show for the first time that CISD2 is involved in mammalian life-span control. Cisd2 deficiency in mice causes mitochondrial breakdown and dysfunction accompanied by autophagic cell death, and these events precede the two earliest manifestations of nerve and muscle degeneration; together, they lead to a panel of phenotypic features suggestive of premature aging. Our study also reveals that Cisd2 is primarily localized in the mitochondria and that mitochondrial degeneration appears to have a direct phenotypic consequence that triggers the accelerated aging process in Cisd2 knockout mice; furthermore, mitochondrial degeneration exacerbates with age, and the autophagy increases in parallel to the development of the premature aging phenotype. Additionally, our Cisd2 knockout mouse work provides strong evidence supporting an earlier clinical hypothesis that WFS is in part a mitochondria-mediated disorder; specifically, we propose that mutation of CISD2 causes the mitochondria-mediated disorder WFS2 in humans. Thus, this mutant mouse provides an animal model for mechanistic investigation of Cisd2 protein function and help with a pathophysiological understanding of WFS2.

    Keywords

    Footnotes

    | Table of Contents

    Life Science Alliance